pABA通过抑制氨基酸摄取和蛋白质泛素化调控真菌胞质分裂的分子机制研究

负责人:PEDRO LABORDA MARTINEZ

依托单位:南通大学

批准年份:2021

前往基金查询
项目简介
项目名称
pABA通过抑制氨基酸摄取和蛋白质泛素化调控真菌胞质分裂的分子机制研究
项目批准号
学科分类
暂无数据
资助类型
暂无数据
负责人
PEDRO LABORDA MARTINEZ
依托单位
南通大学
批准年份
2021
起止时间
202201-202612
批准金额
58.00万元
摘要
暂无数据
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241495, encodeId=5e43124149589, content=<a href='/topic/show?id=7d0764900ce' target=_blank style='color:#2F92EE;'>#泛素化#</a>, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64900, encryptionId=7d0764900ce, topicName=泛素化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 12:25:41 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228528, encodeId=d32b122852895, content=分子机制研究, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f228216135, createdName=ms3000000243944303, createdTime=Sat Jun 25 00:01:08 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227178, encodeId=1133122e178d4, content=有用, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sat Jun 18 10:40:41 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227404, encodeId=adcb122e40481, content=高端, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sun Jun 19 19:51:31 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217299, encodeId=a85d121e299e8, content=😂, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f9c8127516, createdName=ms3000000241036675, createdTime=Fri May 06 10:28:33 CST 2022, time=2022-05-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1241495, encodeId=5e43124149589, content=<a href='/topic/show?id=7d0764900ce' target=_blank style='color:#2F92EE;'>#泛素化#</a>, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64900, encryptionId=7d0764900ce, topicName=泛素化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 12:25:41 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228528, encodeId=d32b122852895, content=分子机制研究, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f228216135, createdName=ms3000000243944303, createdTime=Sat Jun 25 00:01:08 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227178, encodeId=1133122e178d4, content=有用, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sat Jun 18 10:40:41 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227404, encodeId=adcb122e40481, content=高端, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sun Jun 19 19:51:31 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217299, encodeId=a85d121e299e8, content=😂, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f9c8127516, createdName=ms3000000241036675, createdTime=Fri May 06 10:28:33 CST 2022, time=2022-05-06, status=1, ipAttribution=)]
    2022-06-25 ms3000000243944303

    分子机制研究

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241495, encodeId=5e43124149589, content=<a href='/topic/show?id=7d0764900ce' target=_blank style='color:#2F92EE;'>#泛素化#</a>, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64900, encryptionId=7d0764900ce, topicName=泛素化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 12:25:41 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228528, encodeId=d32b122852895, content=分子机制研究, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f228216135, createdName=ms3000000243944303, createdTime=Sat Jun 25 00:01:08 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227178, encodeId=1133122e178d4, content=有用, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sat Jun 18 10:40:41 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227404, encodeId=adcb122e40481, content=高端, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sun Jun 19 19:51:31 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217299, encodeId=a85d121e299e8, content=😂, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f9c8127516, createdName=ms3000000241036675, createdTime=Fri May 06 10:28:33 CST 2022, time=2022-05-06, status=1, ipAttribution=)]
    2022-06-18 ms5000000017582341

    有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1241495, encodeId=5e43124149589, content=<a href='/topic/show?id=7d0764900ce' target=_blank style='color:#2F92EE;'>#泛素化#</a>, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64900, encryptionId=7d0764900ce, topicName=泛素化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 12:25:41 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228528, encodeId=d32b122852895, content=分子机制研究, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f228216135, createdName=ms3000000243944303, createdTime=Sat Jun 25 00:01:08 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227178, encodeId=1133122e178d4, content=有用, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sat Jun 18 10:40:41 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227404, encodeId=adcb122e40481, content=高端, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sun Jun 19 19:51:31 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217299, encodeId=a85d121e299e8, content=😂, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f9c8127516, createdName=ms3000000241036675, createdTime=Fri May 06 10:28:33 CST 2022, time=2022-05-06, status=1, ipAttribution=)]
    2022-06-19 ms5000000017582341

    高端

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1241495, encodeId=5e43124149589, content=<a href='/topic/show?id=7d0764900ce' target=_blank style='color:#2F92EE;'>#泛素化#</a>, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64900, encryptionId=7d0764900ce, topicName=泛素化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 12:25:41 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228528, encodeId=d32b122852895, content=分子机制研究, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f228216135, createdName=ms3000000243944303, createdTime=Sat Jun 25 00:01:08 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227178, encodeId=1133122e178d4, content=有用, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sat Jun 18 10:40:41 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227404, encodeId=adcb122e40481, content=高端, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca18208267, createdName=ms5000000017582341, createdTime=Sun Jun 19 19:51:31 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217299, encodeId=a85d121e299e8, content=😂, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f9c8127516, createdName=ms3000000241036675, createdTime=Fri May 06 10:28:33 CST 2022, time=2022-05-06, status=1, ipAttribution=)]
    2022-05-06 ms3000000241036675

    😂

    0